Thermo Fisher Scientific (TMO) Deferred Taxes (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Deferred Taxes for 18 consecutive years, with -$208.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Deferred Taxes rose 35.4% year-over-year to -$208.0 million; the trailing twelve-month figure through Jun 2026 stood at -$504.0 million (up 58.1% YoY), and the FY2025 full-year result was -$639.0 million, up 47.15% from the prior year.
• Deferred Taxes improved to -$208.0 million in Q2 2026 per TMO's latest filing, from -$258.0 million in the prior quarter.
• Across five years, Deferred Taxes topped out at $339.0 million in Q2 2022 and bottomed at -$1.9 billion in Q4 2023.
• Historically, Deferred Taxes has averaged -$145.5 million across 5 years, with a median of -$19.0 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Deferred Taxes surged 1512.5% in 2022, then slumped 1551.88% in 2023.
• Over 5 years, Deferred Taxes stood at $133.0 million in 2022, then plunged by 1551.88% to -$1.9 billion in 2023, then surged by 89.54% to -$202.0 million in 2024, then surged by 144.06% to $89.0 million in 2025, then plunged by 333.71% to -$208.0 million in 2026.
• According to Business Quant data, Deferred Taxes over the past three periods registered -$208.0 million, -$258.0 million, and $89.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.